PmRN newsletter 1

Overview

There is a significant need for research and development on paediatric medicines. Only a limited number of medicines that are currently available have been clinically evaluated for their safety and efficacy in the paediatric population. Following the recommendations from the 13th International Conference of Drug Regulatory Authorities (ICDRA) a Paediatric medicines Regulators’ Network (PmRN) has been established with representatives from National Medicines Regulatory Authorities.